stockrowArvinas, Inc. (ARVN) vs Gyre Therapeutics, Inc. (GYRE)
- Arvinas, Inc. ARVN 6.39 −2.44%
- Gyre Therapeutics, Inc. GYRE 4.72 +17.71%
Arvinas, Inc. and Gyre Therapeutics, Inc. are both Biotechnology companies. Arvinas, Inc. and Gyre Therapeutics, Inc. are of similar size ($428.9M and $425.2M). Gyre Therapeutics, Inc. grew revenue faster over the last twelve months: 13.5% against −11.9%. Arvinas, Inc. has the higher net margin (−3.45% vs −21.5%) and the higher return on invested capital (0.00% vs −8.51%). Across the 18 metrics below, Arvinas, Inc. leads on 12 and Gyre Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ARVN | GYRE | Biotechnology median |
|---|---|---|---|
| Gross margin | 96.69% | 91.71% | 68.51% |
| Operating margin | (12.13%) | 0.00% | 0.00% |
| Net margin | (3.45%) | (21.46%) | 0.00% |
| Free cash flow margin | (58.05%) | (19.94%) | 0.00% |
| Return on equity | (1.76%) | (18.54%) | (51.96%) |
| Return on assets | (1.31%) | (14.49%) | (46.06%) |
| Return on invested capital | 0.00% | (8.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack